Search Results
Jul 15, 2025, 09:00 ET Shareholders that lost money on Hims & Hers Health, Inc.(HIMS) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
July 15, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Jul 15, 2025, 08:09 ET HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations
More news about: The Schall Law Firm
Jul 14, 2025, 14:23 ET HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
disclose that: (1) the communication between Hims and the pharmaceutical company Novo Nordisk A/S ("Novo") would facilitate a long-term collaboration that would ensure continued access to the weight-loss drug Wegovy for Hims subscribers; (2) Novo approved of Hims' offerings of compounded semaglutide products
More news about: THE ROSEN LAW FIRM, P. A.
Jul 14, 2025, 09:00 ET Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - August 25, 2025 Deadline to Join - Contact The Gross Law Firm
July 14, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).
More news about: The Gross Law Firm
Jul 12, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Jul 11, 2025, 22:09 ET HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased the Company's securities between April 29, 2025 and June
More news about: ClaimsFiler
Jul 11, 2025, 09:00 ET Hims & Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - HIMS
July 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Jul 11, 2025, 06:12 ET June in Review: 14 Top Health Press Releases
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketingIn support of transitioning patients
More news about: PR Newswire
Jul 11, 2025, 06:02 ET 14 Top Press Releases from June
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing"Novo Nordisk is firm on our position
More news about: PR Newswire
Jul 10, 2025, 16:06 ET CLASS ACTION REMINDER: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025
securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).
More news about: Berger Montague
Jul 10, 2025, 12:00 ET Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS).
More news about: Glancy Prongay & Murray LLP
Jul 10, 2025, 09:00 ET Shareholders that lost money on Hims & Hers Health, Inc.(HIMS) should contact The Gross Law Firm about pending Class Action - HIMS
July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).
More news about: The Gross Law Firm
Jul 09, 2025, 12:00 ET Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
investors with losses related to Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) have opportunity to lead the
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Jul 09, 2025, 09:37 ET Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - HIMS
of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations
More news about: DJS Law Group LLP
Jul 09, 2025, 09:37 ET HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations
More news about: The Schall Law Firm
Jul 09, 2025, 09:30 ET INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v. Hims & Hers Health, Inc., No. 25-cv-05315 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers and certain of Hims & Hers' top executives with violations
More news about: Robbins Geller Rudman & Dowd LLP
Jul 08, 2025, 15:19 ET INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims & Hers Health Inc. to Contact Law Firm
announcing that it was terminating its partnership with Hims & Hers, citing "Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk." The press release stated that Hims & Hers "has failed to adhere to the law which prohibits
More news about: Moore Law PLLC
Jul 08, 2025, 10:35 ET HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) and reminds investors of the August 25, 2025 deadline to seek the role of lead plaintiff
More news about: Faruqi & Faruqi, LLP
Jul 08, 2025, 09:00 ET Hims & Hers Health, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - HIMS
July 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Jul 07, 2025, 16:11 ET CLASS ACTION NOTICE: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Class Action
securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS).
More news about: Berger Montague
Jul 07, 2025, 14:45 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Jul 07, 2025, 10:07 ET HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
disclose that: (1) the communication between Hims and the pharmaceutical company Novo Nordisk A/S ("Novo") would facilitate a long-term collaboration that would ensure continued access to the weight-loss drug Wegovy for Hims subscribers; (2) Novo approved of Hims' offerings of compounded semaglutide products
More news about: THE ROSEN LAW FIRM, P. A.
Jul 07, 2025, 09:00 ET Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for Investors - Contact The Gross Law Firm
July 7, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).
More news about: The Gross Law Firm
Jul 07, 2025, 04:04 ET Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights
a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Hims & Hers Health, Inc. (NYSE: HIMS) ("Hims & Hers" or the "Company") securities between April 29, 2025 and June
More news about: Wolf Haldenstein Adler Freeman & Herz LLP
Jul 06, 2025, 23:49 ET HIMS INVESTOR ALERT: Edelson Lechtzin LLP Urges Hims & Hers Health, Inc. (NYSE: HIMS) Shareholders to Consult an Attorney About the Impending Lead Plaintiff Deadline in the Securities Fraud Class Action
law firm, is investigating securities fraud claims on behalf of all investors of Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS) who purchased stock pursuant to and/or traceable to Hims & Hers' statement announcing its long-term partnership with Novo Nordisk A/S on April
More news about: Edelson Lechtzin LLP